Cubist Systematic Strategies’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,000
Closed -$977K 4287
2024
Q1
$977K Buy
3,000
+800
+36% +$196K 0.01% 2191
2023
Q4
$419K Buy
+2,200
New +$416K ﹤0.01% 2611
2023
Q3
Sell
-2,600
Closed -$742K 4106
2023
Q2
$742K Buy
2,600
+1,500
+136% +$417K ﹤0.01% 2143
2023
Q1
$239K Buy
+1,100
New +$214K ﹤0.01% 3133

Other funds holding SWAV

Cubist Systematic Strategies's SWAV Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 11,052 shares — an estimated $3.6M sold.

Cubist Systematic Strategies first reported a position in SWAV in Q2 2019 and held it in 18 quarters. The position peaked at $19.8M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 11,052 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.6M.
  • Cubist Systematic Strategies first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Cubist Systematic Strategies's Shockwave Medical, Inc. Common Stock position peaked at $19.8M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.